Anzeige
Mehr »
Donnerstag, 10.07.2025 - Börsentäglich über 12.000 News
Millionenschwerer Einstieg!: Ein europäischer Finanzriese setzt auf dieses Projekt - folgen Sie den Profis?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLA | ISIN: FR0010609263 | Ticker-Symbol: 1MK
Frankfurt
10.07.25 | 08:05
0,089 Euro
-0,45 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MAUNA KEA TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MAUNA KEA TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
0,1260,13422:16

Aktuelle News zur MAUNA KEA TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MAUNA KEA TECHNOLOGIES Aktie jetzt für 0€ handeln
19:18Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure281Bridge financing through the issuance of convertible bonds to Vester Finance and European investors for €1.8m Immediate receipt of the entire financing upon signing Cash runway extended to...
► Artikel lesen
17:48Mauna Kea Technologies Reaches Key Milestone in its Safeguard Procedure175Structuring of financing in progress to secure the safeguard period and support long-term development plan Authorization to implement the classes of affected parties proceeding, paving the way...
► Artikel lesen
MoMauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital172Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
05.06.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital278Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
05.06.Mauna Kea Technologies Announces Results of Its Combined General Meeting of June 5, 2025394All the resolutions proposed by the Board of Directors were adopted Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and...
► Artikel lesen
02.06.Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification411Cellvizio technology combined with AI outperforms human experts in pancreatic cyst risk stratification, a major breakthrough for patient management Results build on new CLIMB study data recently...
► Artikel lesen
21.05.Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress372Ongoing Strategic Negotiations Towards a Licensing Agreement Strong Momentum for CellTolerance: Over 1,500 Procedures Completed, New Centers of Excellence Adopting the Technology, Including a...
► Artikel lesen
20.05.Mauna Kea Technologies Announces the Availability of Preparatory Documents for the Combined General Meeting of June 5, 2025 and the Instructions for Participation605Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced...
► Artikel lesen
06.05.Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week 2025794Over 75 physicians attended educational presentations about the breakthrough impact of needle-based Confocal Laser Endomicroscopy and AI on the diagnosis and treatment of pancreatic cystic lesions...
► Artikel lesen
05.05.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital577Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
30.04.Mauna Kea Technologies: Publication of the 2024 Annual Financial Report746Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced...
► Artikel lesen
28.04.Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio in Key Indications352Pancreatic cyst abstracts build on endorsement of Cellvizio by Europe's leading endoscopy society, ESGE, as a key tool for improving pancreatic cyst diagnostic accuracy AI, pancreatic cancer...
► Artikel lesen
24.04.Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update869Commercial activities remain strong, including CellTolerance launch Recently approved safeguard proceeding yielding productive creditor and investor discussions aimed at strengthening Mauna Kea's...
► Artikel lesen
07.04.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital266Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Listing: Euronext Growth Paris Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing:...
► Artikel lesen
01.04.Mauna Kea Technologies Announces Entrance Into Exclusive Negotiations for a Licensing Agreement for Cellvizio in an Important Therapeutic Area With a Major Industry Player384The Company also confirms that it is pursuing licensing discussions in other therapeutic areas The protective framework of the safeguard proceedings enables Mauna Kea Technologies to intensify...
► Artikel lesen
31.03.Mauna Kea Technologies Announces the Opening of a Safeguard Proceeding to Restructure Its Financial Liabilities611The aim of the procedure is to optimize the Company's financial structure in order to adapt it to the needs of its future growth The procedure will also provide a protective framework favorable...
► Artikel lesen
06.03.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital299Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
03.03.Mauna Kea Technologies: Cellvizio Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis351ESGE, Europe's leading endoscopy society, endorses Cellvizio® as a key tool for improving pancreatic cyst diagnostic accuracy, marking a major step towards broader commercial adoption Regulatory...
► Artikel lesen
06.02.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital310Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
27.01.Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio for Precision Surgery in Head and Neck Cancers429Cellvizio was successfully integrated into TransOral Robotic Surgery (TORS) procedures to assess peripheral mucosal margins in the larynx, oropharynx and hypopharynx Cellvizio helped identify...
► Artikel lesen
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1